… To further dissect the relationship between immunogenicity and protection in SARS-CoV-2
we considered the parallels with previous approaches to estimating a ‘50% protective titer’ in …

… neutralizing antibodies are considered linked to protective immunity … antibodies after
vaccination without being able to provide a threshold below which protection against SARS-CoV-2 …

… -positive individual with new positive PCR test 4 weeks after the first antibody positive test)
infections occurred in the SARS-CoV-2-experienced cohort. Additionally, 864 individuals in …

… of protection from symptomatic infection with a similar virus. Here we extend that work to
show that neutralising antibodies are also highly predictive of protection from SARS-CoV-2 …

… to offer greater resistance to SARS-CoV-2 escape than single antibodies. Our results provide
a … antibodies as candidates for use as COVID-19 immunotherapeutic agents in humans. …

… antibodies (4). Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and
demonstrate their in vivo protective … To investigate the antibody response against SARS-CoV-2 …

… SARS-CoV-2 S RBD would affect antibody neutralization, we used HIV-1 virus pseudotyped
with the SARS-CoV-2-MA … contributes to optimal protection against SARS-CoV-2 MA in vivo. …

… First, comprehensive studies are urgently needed to define clinical correlates of protective
immunity against SARS-CoV-2. Second, because ADE of disease cannot be reliably predicted …

… Although evidence for the primacy of those antibodies for protection will be presented below,
… of the antibody are required for protection against SARS-CoV-2 has been poorly studied. …

… To address this, we compared SARSCoV-2 and OC43 IgG antibody titers in the serum of
individuals in our cohort who had samples collected within one year of the pandemic (between …